SALBUTAMOL 8 - Adelphi Research

Salbutamol, released in 1980 under the trade name Ventolin, quickly became a frontline treatment for asthma due to its rapid beta-2 adrenergic stimulation and low cardiovascular impact. Originally developed for inhalation to minimize systemic effects, the compound later became available in oral form, extending its use beyond respiratory therapy. In the bodybuilding and athletic world, oral salbutamol gained attention for its fat-burning potential and mild anabolic preservation, offering a legal alternative to clenbuterol in some countries.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about SALBUTAMOL 8 by Adelphi Research, consult with your doctor or healthcare professional.